# MC-5A for Chemotherapy Induced Peripheral Neuropathy

> **NCT01261780** · PHASE2 · COMPLETED · sponsor: **University of Wisconsin, Madison** · enrollment: 14 (actual)

## Conditions studied

- Neuropathy, Paraneoplastic

## Interventions

- **DEVICE:** MC-5A
- **DRUG:** Sham device

## Key facts

- **NCT ID:** NCT01261780
- **Lead sponsor:** University of Wisconsin, Madison
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2012-09
- **Final completion:** 2012-09
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2019-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01261780

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01261780, "MC-5A for Chemotherapy Induced Peripheral Neuropathy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01261780. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*